Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. CBRS
3. FDX
4. USO
5. MU
6. SPY
7. KBH
8. HON
9. HTZ
10. MRK

Go back to Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States
Asianada, Inc. (NASDAQ: ASND) Delayed: 238.01 -0.58 (0.24%)
Previous Close $238.59    52 Week High $21.79 
Open $239.86    52 Week Low $11.92 
Day High $241.79    P/E N/A 
Day Low $237.33    EPS $-0.07 
Volume 476,279